| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/07/1998 | CA2270345A1 Immunostimulatory nucleic acid molecules |
| 05/06/1998 | EP0839205A1 Liver-specific adenovirus expression vector |
| 05/06/1998 | EP0839157A1 Colostrum derived growth factor |
| 05/06/1998 | EP0839137A1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 05/06/1998 | EP0839052A1 Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
| 05/06/1998 | EP0839038A1 THERAPEUTIC USE OF d-threo-METHYLPHENIDATE |
| 05/06/1998 | EP0839032A1 Hydroxyl ions as unique therapeutic agents and compounds that modulate ions, compounds |
| 05/06/1998 | EP0740652B1 Metalloproteinase inhibitors |
| 05/06/1998 | EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 05/06/1998 | EP0438519B1 Therapeutic peptides |
| 05/06/1998 | CN1181084A Tricyclic benzazepine vasopression antagonists |
| 05/06/1998 | CN1181075A Substituted isoxazoles for the treatment of inflammation |
| 05/06/1998 | CN1181066A Arylsulfonylamino hydroxamic acid derivatives |
| 05/06/1998 | CN1180568A Hepatitis B virus converting negative tablet |
| 05/06/1998 | CN1180552A Tooth-care article |
| 05/05/1998 | US5747541 Substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic agent, and medicament comprising them |
| 05/05/1998 | US5747514 Metalloproteinase inhibitors |
| 05/05/1998 | US5747491 Morpholine derivatives and their use as antagonists of tachikinins |
| 05/05/1998 | US5747477 Azo derivatives of 5-aminosalicylic acid |
| 05/05/1998 | US5747318 Mitogen activated c-Fos regulating kinase, FRK |
| 05/05/1998 | US5747303 Intermediates of peptide antagonists of neurotensin |
| 05/05/1998 | US5747040 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 05/05/1998 | US5746995 Diethylenetriaminepentaacetic acid |
| 04/30/1998 | WO1998017801A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-α NUCLEIC ACIDS |
| 04/30/1998 | WO1998017685A1 Novel lanthionine antibiotic compositions and methods |
| 04/30/1998 | WO1998017663A1 Novel genipin derivative having anti hepatitis b virus activity |
| 04/30/1998 | WO1998017655A1 Metalloproteinase inhibitors |
| 04/30/1998 | WO1998017645A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS |
| 04/30/1998 | WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 04/30/1998 | WO1998017627A1 Substituted gamma aminobutyric acids as pharmaceutical agents |
| 04/30/1998 | WO1998017195A1 COMPOSITIONS TO CONTROL ORAL MICROBIAL OXIDATION-REDUCTION (Eh) LEVELS |
| 04/30/1998 | WO1998004694A3 Secreted proteins and polynucleotides encoding them |
| 04/30/1998 | CA2269283A1 Metalloproteinase inhibitors |
| 04/30/1998 | CA2269100A1 Methods and compositions for delivery and expression of interferon-.alpha. nucleic acids |
| 04/30/1998 | CA2268744A1 Novel lanthionine antibiotic compositions and methods |
| 04/30/1998 | CA2268418A1 .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/29/1998 | EP0838523A2 RsbW-1 derived from Staphylococcus |
| 04/29/1998 | EP0838469A1 10,13,15-Trioxatricy-clo(9.2.1.1. 9.6)-pentadecanon derivatives, process for their preparation and medicament containing them |
| 04/29/1998 | EP0838453A1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/29/1998 | EP0838221A1 Lyophilized hgf preparations |
| 04/29/1998 | EP0838213A1 Use of Krill Enzymes for the Treatment of Dental Plaque |
| 04/29/1998 | EP0837951A1 Antisense inhibition of hepatitis b virus replication |
| 04/29/1998 | EP0837939A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 04/29/1998 | EP0837880A2 Enamel matrix related polypeptide |
| 04/29/1998 | EP0837697A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits |
| 04/29/1998 | EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue |
| 04/29/1998 | EP0837685A2 Use of indigestible oligosaccharides to prevent and treat diarrhea |
| 04/29/1998 | EP0536269B1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/29/1998 | CN1180358A Bridged indoles as matrix metalloprotease inhibitors |
| 04/29/1998 | CN1180357A 5H, 10H-imidazo £1, 2 -a| indeno £1, 2 -e| pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives |
| 04/29/1998 | CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 04/29/1998 | CN1179980A Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases |
| 04/29/1998 | CN1179953A Complete set of Chinese medicine preparations for curing hepatitis B |
| 04/28/1998 | US5744641 Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 04/28/1998 | US5744607 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 04/28/1998 | US5744493 3-amidopyrazole derivatives and pharmaceutical compositions containing them |
| 04/28/1998 | US5744491 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 04/28/1998 | US5744489 Administering certain 1,2,5-thiadiazole and 1,2,5-oxadiazole compounds |
| 04/28/1998 | US5744157 Preparation for maintaining and/or increasing muscular power and body cell mass |
| 04/28/1998 | US5744134 Immunoglobulin and fiber-containing composition for human gastrointestinal health |
| 04/28/1998 | CA2077653C Phenyl butyl nitrone compositions for prevention of gastric ulceration |
| 04/23/1998 | WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS |
| 04/23/1998 | WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | WO1998016502A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 04/23/1998 | WO1998016266A1 Implantable acrylamide copolymer hydrogel for therapeutic uses |
| 04/23/1998 | WO1998016243A1 Uses of keratinocyte growth factor-2 |
| 04/23/1998 | WO1998016229A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 04/23/1998 | WO1998016184A2 Purine l-nucleosides, analogs and uses thereof |
| 04/23/1998 | WO1998016111A1 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 04/23/1998 | WO1998009992A3 Htm4, methods of treatment and assays, agonists and antagonists |
| 04/23/1998 | WO1998004702A3 Proteins, in particular membrane proteins, of helicobacter pylori, their preparation and use |
| 04/23/1998 | CA2452540A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | CA2268897A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268895A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268894A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 04/23/1998 | CA2268103A1 Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
| 04/23/1998 | CA2268098A1 Aspartate ester inhibitors of interleukin-1.beta. converting enzyme |
| 04/23/1998 | CA2266889A1 Purine l-nucleosides, analogs and uses thereof |
| 04/22/1998 | EP0837073A1 Human mad proteins and uses thereof |
| 04/22/1998 | EP0836852A1 Use of amlexanox for the manufacture of a medicament for treating aphtous ulcers |
| 04/22/1998 | EP0836621A1 Novel human g-protein coupled receptor |
| 04/22/1998 | EP0836617A1 Parevins and tachytegrins |
| 04/22/1998 | EP0836477A1 Antibacterial synergistic composition comprising rifabutin |
| 04/22/1998 | EP0618906B1 Substituted imidazole derivatives and their preparation and use |
| 04/22/1998 | CN1179774A Arginine analogues having nitric oxide synthase inhibitor activity |
| 04/22/1998 | CN1179323A Chinese medicine for treating hepatitis B and preparing process thereof |
| 04/22/1998 | CN1179322A Powder for removing infantile malnutrition |
| 04/22/1998 | CN1179307A Liquid antiacid compositions |
| 04/22/1998 | CN1038131C Pyrrolopyrimidines and its preparing intermediate and medicinal composition containing same and use |
| 04/21/1998 | US5741910 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
| 04/21/1998 | US5741892 Pentapeptides as antitumor agents |
| 04/21/1998 | US5741815 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor |
| 04/21/1998 | US5741810 Prostaglandins for ocular hypotension for treatment of glaucoma |
| 04/21/1998 | US5741809 Compounds and methods for the treatment of cardiovascular inflammatory and immune disorders |
| 04/21/1998 | US5741806 Suppository compositions containing ondasetron dihydrate |
| 04/21/1998 | US5741797 Heteroatom substituted alkyl benzylaminoquinuclidines |
| 04/21/1998 | US5741790 Tachykinin antagonist and intermediates for nervous system disorders, antiinflammatory agents, antiarthritic agents, antidepressants and gastrointestinal disorders |
| 04/21/1998 | US5741788 Heterocyclic compounds and their preparation and use |